Genetic Technologies (AU:GTG) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Genetic Technologies Limited has successfully completed the sale of its geneType business and assets to Rhythm Biosciences, marking a significant move in the genomic diagnostics sector. The transaction, finalized on December 23, 2024, involves a seamless transition with the support of both companies. This development reflects ongoing shifts in the market as companies adapt and restructure towards innovative growth.
For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.
